EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting

Anna Pocurull, Elia Canga, Luis González-de Paz, Joaquín Sáez-Peñataro, Naira Rico, Maria Calvo-Orteu, Mireia Sans-Corrales, Carlos Gómez, Antoni Sisó-Almirall, Xavier Forns

Clinical Gastroenterology and Hepatology · 2026-06

DOI: 10.1016/j.cgh.2026.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-06. Verfasst von Anna Pocurull und 9 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Cen…. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Catalonia Department of Business and Knowledge, Carlos III Health Institute, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Idiosyncratic drug-induced liver injury is a growing clinical concern, but its burden in primary care remains poorly defined. In this setting, polypharmacy is common, and mild cases may go unrecognized. We aimed to determine the incidence, clinical characteristics, and outcomes of drug-induced liver injury in a large primary care population and to evaluate the diagnostic accuracy of laboratory alert criteria. METHODS: We conducted a prospective population-based study across 3 primary care centers in Barcelona (adult population, 91,798) from August 2022 to July 2024. An automated laboratory alert system triggered an alert for patients meeting predefined biochemical thresholds (alanine aminotransferase ≥5 × upper limit of normal, alkaline phosphatase ≥2 × upper limit of normal, or alanine aminotransferase ≥3 × upper limit of normal with bilirubin >2 × upper limit of normal). Expert hepatologists reviewed all identified cases to establish the most likely etiology. RESULTS: Among 38,112 patients undergoing laboratory tests, 153 met alert criteria, and 20 were diagnosed with drug-induced liver injury, yielding an annual incidence of 10.9 cases per 100,000 inhabitants (95% confidence interval, 6.7-16.8). All cases were mild, predominantly hepatocellular (70%), and resolved after drug withdrawal. Alanine aminotransferase ≥5 × upper limit of normal demonstrated the highest positive predictive value (25%) for drug-induced liver injury. Analgesics (40%), statins (20%), and dietary/herbal supplements (20%) were the most frequent causative agents. Relative incidence per 10,000 prescriptions was highest for metamizole (4.5) and diclofenac (3.5). CONCLUSIONS: Drug-induced liver injury represents a relevant cause of liver enzyme abnormalities in the primary care setting and is typically associated with favorable outcomes. Alanine aminotransferase ≥5 × upper limit of normal is the most reliable alert criterion, and analgesics, statins, and supplements are the leading culprits. Laboratory-linked alert systems may enhance early drug-induced liver injury detection in community practice.

Schlagwörter

Stichwörter der Autor:innen

Alert SystemCulprit MedicationsDrug-Induced Liver Injury (DILI)Incidence of DILIPrimary Care

Autor:innen und Institutionen

  • Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Hepatología y Gastroenterolog…
  • Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Hepatología y Gastroenterología (CIBEREHD), Spain; Faculty of Nursing, University of Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain; Nursing Department of Public Health, Mental Healt…
  • Clinical Pharmacology Department, Pharmacovigilance Program, Hospital Clínic, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Core Laboratory, Biochemistry and Molecular Genetics Service, CDB, Hospital Clínic, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Faculty of Medicine, University of Barcelona, Barcelona, Spain; Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Bar…

Förderung

  • Government of Catalonia Department of Business and Knowledge
  • Carlos III Health Institute
  • Generalitat de Catalunya
  • Centres de Recerca de Catalunya

Zitieren

APA

Pocurull, A., Canga, E., González-de Paz, L., Sáez-Peñataro, J., Rico, N., Calvo-Orteu, M., Sans-Corrales, M., Gómez, C., Sisó-Almirall, A., & Forns, X. (2026). Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.06.014

Vancouver

Pocurull A, Canga E, González-de Paz L, Sáez-Peñataro J, Rico N, Calvo-Orteu M, et al. Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.06.014

BibTeX
@article{Pocurull2026,
  author = {Pocurull, Anna and Canga, Elia and González-de Paz, Luis and Sáez-Peñataro, Joaquín and Rico, Naira and Calvo-Orteu, Maria and Sans-Corrales, Mireia and Gómez, Carlos and Sisó-Almirall, Antoni and Forns, Xavier},
  title = {Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.06.014}
}
Kostenlos starten →